drugset / Trial / NCT00392002
Examine National Characteristics & Outcome Measures of GERD Patients Using the PPI Acid Suppression Symptom (PASS) Test for Response
RandomizedParallel-groupOpen-labelTreatment
Summary
To characterize the burden of disease in GERD patients of prescription therapy'
Timeline
- Start
- 2005-10
- Primary completion
- —
- Completion
- 2007-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Esomeprazole | Small molecule | 20 mg | — |
| Subject | Esomeprazole | Small molecule | 40 mg | — |